Covered recipient · General Payments record
SWAPNA KODURU
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$3,817.00
- Reported across 252 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $595.73 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $167.50 | 7 |
| ABBVIE INC. | $133.82 | 10 |
| Janssen Biotech, Inc. | $66.93 | 3 |
| UCB, Inc. | $65.57 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $49.03 | 2 |
| GlaxoSmithKline, LLC. | $37.35 | 2 |
| E.R. Squibb & Sons, L.L.C. | $33.25 | 2 |
| Actelion Pharmaceuticals US, Inc. | $25.57 | 1 |
| Kyowa Kirin, Inc. | $16.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.58 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104092136 | CMS |
| ABBVIE INC. | $4.63 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104092138 | CMS |
| ABBVIE INC. | $3.84 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104092140 | CMS |
| ABBVIE INC. | $7.73 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104092142 | CMS |
| ABBVIE INC. | $12.81 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104092144 | CMS |
| ABBVIE INC. | $14.06 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104092146 | CMS |
| ABBVIE INC. | $23.93 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104092148 | CMS |
| ABBVIE INC. | $22.39 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104092150 | CMS |
| ABBVIE INC. | $23.04 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104092152 | CMS |
| ABBVIE INC. | $13.81 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104092154 | CMS |
| Actelion Pharmaceuticals US, Inc. | $25.57 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078914901 | CMS |
| Amgen Inc. | $11.02 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115822095 | CMS |
| Amgen Inc. | $11.83 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115822103 | CMS |
| Amgen Inc. | $32.23 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117600867 | CMS |
| Amgen Inc. | $25.19 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115822069 | CMS |
| Amgen Inc. | $29.86 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115822080 | CMS |
| Amgen Inc. | $23.58 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115822087 | CMS |
| Amgen Inc. | $33.79 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115822114 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.73 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101824802 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.52 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101824868 | CMS |
| GlaxoSmithKline, LLC. | $17.50 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115918516 | CMS |
| GlaxoSmithKline, LLC. | $19.85 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116689423 | CMS |
| Janssen Biotech, Inc. | $13.25 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078679944 | CMS |
| Janssen Biotech, Inc. | $33.05 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078680105 | CMS |
| Janssen Biotech, Inc. | $20.63 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078680085 | CMS |
| Kyowa Kirin, Inc. | $16.71 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127044289 | CMS |
| Novartis Pharmaceuticals Corporation | $26.44 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087138606 | CMS |
| Novartis Pharmaceuticals Corporation | $22.59 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087138612 | CMS |
| UCB, Inc. | $33.59 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143469890 | CMS |
| UCB, Inc. | $31.98 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143469894 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.